OCHROMYCINONE

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Investigational

Investigational

Details

Stereochemistry	ABSOLUTE
Molecular Formula	C19H14O4
Molecular Weight	306.3121
Optical Activity	UNSPECIFIED
Defined Stereocenters	1 / 1
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure of OCHROMYCINONE

Structure Search

SMILES

C[C@@H]1CC(=O)C2=C3C(=O)C4=C(C(O)=CC=C4)C(=O)C3=CC=C2C1

InChI

InChIKey=ZAWXOCUFQSQDJS-VIFPVBQESA-N

InChI=1S/C19H14O4/c1-9-7-10-5-6-12-17(15(10)14(21)8-9)19(23)11-3-2-4-13(20)16(11)18(12)22/h2-6,9,20H,7-8H2,1H3/t9-/m0/s1

HIDE SMILES / InChI

Molecular Formula	C19H14O4
Molecular Weight	306.3121
Charge	0
Count

Stereochemistry	ABSOLUTE
Additional Stereochemistry	No
Defined Stereocenters	1 / 1
E/Z Centers	0
Optical Activity	UNSPECIFIED

Approval Year

Substance Class	Chemical Created by `admin` on `Tue Apr 01 16:39:43 GMT 2025` Edited by `admin` on `Tue Apr 01 16:39:43 GMT 2025`
Record UNII	CKZ6P7I25M
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

J655.169F

Preferred Name

English

OCHROMYCINONE

Common Name

English

BENZ(A)ANTHRACENE-1,7,12(2H)-TRIONE, 3,4-DIHYDRO-8-HYDROXY-3-METHYL-, (S)-

Systematic Name

English

(+)-OCHROMYCINONE

Common Name

English

STA-21

Code

English

(3S)-3.BETA.-METHYL-8-HYDROXY-1,2,3,4,7,12-HEXAHYDROBENZO(A)ANTHRACENE-1,7,12-TRIONE

Systematic Name

English

Code System Code Type Description

DRUG BANK

DB15644

Created by admin on Tue Apr 01 16:39:43 GMT 2025 , Edited by admin on Tue Apr 01 16:39:43 GMT 2025

PRIMARY

CAS

28882-53-3

Created by admin on Tue Apr 01 16:39:43 GMT 2025 , Edited by admin on Tue Apr 01 16:39:43 GMT 2025

PRIMARY

PUBCHEM

11808929

Created by admin on Tue Apr 01 16:39:43 GMT 2025 , Edited by admin on Tue Apr 01 16:39:43 GMT 2025

PRIMARY

FDA UNII

CKZ6P7I25M

Created by admin on Tue Apr 01 16:39:43 GMT 2025 , Edited by admin on Tue Apr 01 16:39:43 GMT 2025

PRIMARY

EPA CompTox

DTXSID40473279

Created by admin on Tue Apr 01 16:39:43 GMT 2025 , Edited by admin on Tue Apr 01 16:39:43 GMT 2025

PRIMARY

Related Record Type Details


					51F8I2CLT3

SIGNAL TRANSDUCER AND ACTIVATOR OF TRANSCRIPTION 3

TARGET -> INHIBITOR

Amount:

Related Record Type Details


					CKZ6P7I25M

ACTIVE MOIETY

Comments:

Examined in an underpowered and non-randomized trial for psoriasis where it showed a promising trend to efficacy, but larger trials are required

Amount: